Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans
- PMID: 17509612
- PMCID: PMC4318564
- DOI: 10.1016/j.yjmcc.2007.04.006
Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans
Abstract
Junctophilin-2 (JPH2) is a cardiac specific member of the junctophilins, a newly characterized family of junctional membrane complex proteins important in physically approximating the plasmalemmal L-type calcium channel and the sarcoplasmic reticulum ryanodine receptor for calcium-induced calcium release. JPH2 knockout mice showed disrupted calcium transients, altered junctional membrane complex formation, cardiomyopathy, and embryonic lethality. Furthermore, JPH2 gene expression is down-regulated in murine cardiomyopathy models. To this end, we explored JPH2 as a novel candidate gene for the pathogenesis of hypertrophic cardiomyopathy (HCM) in humans. Using polymerase chain reaction, denaturing high performance liquid chromatography, and direct DNA sequencing, comprehensive open reading frame/splice site mutational analysis of JPH2 was performed on DNA obtained from 388 unrelated patients with HCM. HCM-associated JPH2 mutations were engineered and functionally characterized using immunocytochemistry, cell morphometry measurements, and live cell confocal calcium imaging. Three novel HCM-susceptibility mutations: S101R, Y141H and S165F, which localize to key functional domains, were discovered in 3/388 unrelated patients with HCM and were absent in 1000 ethnic-matched reference alleles. Functionally, each human mutation caused (i) protein reorganization of junctophilin-2, (ii) perturbations in intracellular calcium signaling, and (iii) marked cardiomyocyte hyperplasia. The molecular and functional evidence implicates defective junctophilin-2 and disrupted calcium signaling as a novel pathogenic mechanism for HCM and establishes HCM as the first human disease associated with genetic defects in JPH2. Whether susceptibility for other cardiomyopathies, such as dilated cardiomyopathy, can be conferred by mutations in JPH2 warrants investigation.
Conflict of interest statement
Figures




Similar articles
-
Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy.J Hum Genet. 2007;52(6):543-548. doi: 10.1007/s10038-007-0149-y. Epub 2007 May 3. J Hum Genet. 2007. PMID: 17476457
-
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling.Circ Heart Fail. 2011 Mar;4(2):214-23. doi: 10.1161/CIRCHEARTFAILURE.110.958694. Epub 2011 Jan 7. Circ Heart Fail. 2011. PMID: 21216834 Free PMC article.
-
Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization.J Am Coll Cardiol. 2013 Nov 19;62(21):2010-9. doi: 10.1016/j.jacc.2013.06.052. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23973696 Free PMC article.
-
Emerging role of junctophilin-2 as a regulator of calcium handling in the heart.Acta Pharmacol Sin. 2010 Sep;31(9):1019-21. doi: 10.1038/aps.2010.116. Epub 2010 Aug 9. Acta Pharmacol Sin. 2010. PMID: 20694023 Free PMC article. Review.
-
One gene, two modes of inheritance, four diseases: A systematic review of the cardiac manifestation of pathogenic variants in JPH2-encoded junctophilin-2.Trends Cardiovasc Med. 2023 Jan;33(1):1-10. doi: 10.1016/j.tcm.2021.11.006. Epub 2021 Dec 1. Trends Cardiovasc Med. 2023. PMID: 34861382 Free PMC article.
Cited by
-
The Builders of the Junction: Roles of Junctophilin1 and Junctophilin2 in the Assembly of the Sarcoplasmic Reticulum-Plasma Membrane Junctions in Striated Muscle.Biomolecules. 2022 Jan 10;12(1):109. doi: 10.3390/biom12010109. Biomolecules. 2022. PMID: 35053257 Free PMC article. Review.
-
Trimeric intracellular cation channels and sarcoplasmic/endoplasmic reticulum calcium homeostasis.Circ Res. 2014 Feb 14;114(4):706-16. doi: 10.1161/CIRCRESAHA.114.301816. Circ Res. 2014. PMID: 24526676 Free PMC article. Review.
-
Salt-induced changes in cardiac phosphoproteome in a rat model of chronic renal failure.PLoS One. 2014 Jun 19;9(6):e100331. doi: 10.1371/journal.pone.0100331. eCollection 2014. PLoS One. 2014. PMID: 24945867 Free PMC article.
-
Overexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress.Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12240-5. doi: 10.1073/pnas.1412729111. Epub 2014 Aug 4. Proc Natl Acad Sci U S A. 2014. PMID: 25092313 Free PMC article.
-
The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity.Biomedicines. 2023 May 27;11(6):1558. doi: 10.3390/biomedicines11061558. Biomedicines. 2023. PMID: 37371654 Free PMC article.
References
-
- Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785–9. - PubMed
-
- Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA. 2002;287:1308–20. - PubMed
-
- Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701–12. - PubMed
-
- Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg H, McKenna W, Seidman CE, et al. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999–1006. - PubMed
-
- Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA095739/CA/NCI NIH HHS/United States
- R01 HL125918/HL/NHLBI NIH HHS/United States
- R01 HL091947/HL/NHLBI NIH HHS/United States
- HD 42569/HD/NICHD NIH HHS/United States
- P01 HL094291/HL/NHLBI NIH HHS/United States
- CA 95739/CA/NCI NIH HHS/United States
- HL 69000/HL/NHLBI NIH HHS/United States
- R01 AG015556/AG/NIA NIH HHS/United States
- R01 HL069000/HL/NHLBI NIH HHS/United States
- AG 15556/AG/NIA NIH HHS/United States
- R01 HL089598/HL/NHLBI NIH HHS/United States
- R01 HD042569/HD/NICHD NIH HHS/United States
- T32 GM072474/GM/NIGMS NIH HHS/United States
- R01 HL117641/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases